Journal article
Two-years biochemical failure-free survival following high intensity focused ultrasound (HIFU) for localized prostate cancer: Prospective single center study of 196 patients
Abstract
5117
Background: HIFU is an emerging ablative modality for the treatment of localized prostate cancer with limited reports on oncological outcome. We prospectively analyzed our 2-year results. Methods: 253 consecutive patients (age: 64+8) were treated with a planed single session of HIFU using the Ablatherm integrated imaging model system between January 2006 and June 2008. Patients were followed (median: 12; range 3–24 …
Authors
Pinthus JH; Farrokhyar F; Hassouna MM; Woods E; Orovan WL
Journal
Journal of Clinical Oncology, Vol. 27, No. 15_suppl, pp. 5117–5117
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2009
DOI
10.1200/jco.2009.27.15_suppl.5117
ISSN
0732-183X